Valuation (7%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -9.92 | N/A |
| PEG Ratio (TTM) | 1.22 | N/A |
| P/S Ratio (TTM) | 383.43 | N/A |
| P/B Ratio (TTM) | 9.50 | N/A |
| P/FCF Ratio (TTM) | -11.46 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -68.73% | N/A |
| ROE (TTM) | -115.71% | N/A |
| Net Profit Margin (TTM) | -3,611.29% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -17.25% | -539.19% | N/A |
| Revenue | -25.00% | N/A | N/A |
| Net Income | -29.46% | -1,291.40% | N/A |
| Cash Flow | -10.63% | -1,059.54% | N/A |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 6.03 | N/A |
| Quick Ratio (TTM) | 6.03 | N/A |
| D/E Ratio (TTM) | 0.14 | N/A |
| Interest Coverage (TTM) | -33.30 | N/A |
| Piotroski F-Score | 1 | N/A |
| Altman Z-Score | 10.66 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |